Skip navigation

Market Dynamics at R4D

Market Dynamics

R4D’s Market Dynamics Practice harnesses the power of the private sector to broaden access to vital goods that positively impact the lives of hundreds of millions globally. R4D has developed strategies to achieve over a billion dollars in efficiency savings and ensure sustainable availability of high-quality products for nutrition, AIDS, malaria, and neglected diseases treatment and prevention. Read more...

Featured Market Dynamics Projects

In February 2011, the Global Fund’s Market Dynamics Committee (MDC) commissioned R4D to develop concrete strategies which optimized ‘value for money’ across its health commodities portfolio, with a particular focus on HIV/AIDS drugs.  

Results for Development (R4D) and Micronutrient Initiative (MI), the leading nonprofit working exclusively to eliminate vitamin and mineral deficiencies in the world’s most vulnerable populations, are undertaking the first of a two-phase Micronutrient Powders Project commissioned by the Bill & Melinda Gates Foundation and focused on developing and scaling the MNP market.

Market Dynamics Projects

In 2012, Market Dynamics Managing Director Kanika Bahl served as co-chair of the Market Shaping Working Group of the UN Commission on Life-Saving Commodities for Women and Children, with the R4D team shaping recommendations for this group. 

Results for Development (R4D) and Micronutrient Initiative (MI), the leading nonprofit working exclusively to eliminate vitamin and mineral deficiencies in the world’s most vulnerable populations, are undertaking the first of a two-phase Micronutrient Powders Project commissioned by the Bill & Melinda Gates Foundation and focused on developing and scaling the MNP market.

In July 2011, the Bill and Melinda Gates Foundation commissioned R4D to identify opportunities to improve the global marketplace for LLINs. R4D rapidly engaged with 70 actors including suppliers, countries, and global financiers and regulators to achieve this. 

Starting in September 2011, with support from the Bill and Melinda Gates Foundation, R4D has been working to increase global PZQ production and developing a set of medium-term market strategies focused on achieving sustainable pricing levels, ensuring high-quality production.

In February 2011, the Global Fund’s Market Dynamics Committee (MDC) commissioned R4D to develop concrete strategies which optimized ‘value for money’ across its health commodities portfolio, with a particular focus on HIV/AIDS drugs.